These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36437645)

  • 21. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Dehner CA; Broski SM; Meis JM; Murugan P; Chrisinger JSA; Sosa C; Petersen M; Halling KC; Gupta S; Folpe AL
    Mod Pathol; 2023 Oct; 36(10):100271. PubMed ID: 37422156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelioid and Spindle Cell Rhabdomyosarcoma of the Oral Mucosa with FUS Rearrangement.
    Ochsner AR; Foss RD
    Head Neck Pathol; 2022 Sep; 16(3):823-827. PubMed ID: 35353344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelioid and spindle cell rhabdomyosarcoma with EWSR1::TFCP2 fusion mimicking metastatic lung cancer: A case report and literature review.
    Haug L; Doll J; Appenzeller S; Kunzmann V; Rosenwald A; Maurus K; Gerhard-Hartmann E
    Pathol Res Pract; 2023 Sep; 249():154779. PubMed ID: 37633005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones.
    Koutlas IG; Olson DR; Rawwas J
    Head Neck Pathol; 2021 Mar; 15(1):374-380. PubMed ID: 32504289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Rare Case Report of Intraosseous Spindle and Epithelioid Rhabdomyosarcoma With
    Si C; Wang Y; Zhu J
    Int J Surg Pathol; 2024 Mar; ():10668969241239676. PubMed ID: 38500382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
    Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
    Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyosarcoma of the skull with EWSR1 fusion and ALK and cytokeratin expression: a case report.
    An HR; Cho KJ; Song SW; Park JE; Song JS
    J Pathol Transl Med; 2024 Sep; 58(5):255-260. PubMed ID: 39228173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Intraosseous Spindle Cell Rhabdomyosarcoma: A Case Report in an Unusual Location.
    Plotzke JM; Rabah R; Robinson DR; Edmonds A; Bloom DA; Mody R; Heider A
    Pediatr Dev Pathol; 2024 Jun; ():10935266241257547. PubMed ID: 38845135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
    Rekhi B; Dodd L; Dharavath B; Dutt A
    Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
    Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
    Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spindle Cell/Sclerosing Rhabdomyosarcoma With
    Rakheja D; Park JY; Alhasan M; Uddin N
    Int J Surg Pathol; 2022 Dec; 30(8):950-955. PubMed ID: 35466752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
    Folpe AL; McKenney JK; Bridge JA; Weiss SW
    Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spindle cell/sclerosing rhabdomyosarcoma with DCTN1::ALK fusion: broadening the molecular spectrum with potential therapeutic implications.
    Fung CK; Chow C; Chan WK; Choi EWK; To KF; Chan JKC; Cheuk W
    Virchows Arch; 2022 Apr; 480(4):927-932. PubMed ID: 35229187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Epithelioid Rhabdomyosarcoma of the Liver: Case Report of an Unusual Histological Variant.
    Nakamura H; Koyanagi Y; Kitamura M; Kukita Y
    Int J Surg Pathol; 2022 May; 30(3):331-334. PubMed ID: 34612734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ZFP64::NCOA3 gene fusion defines a novel subset of spindle cell rhabdomyosarcoma.
    Han R; Dermawan JK; Demicco EG; Ferguson PC; Griffin AM; Swanson D; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2022 Nov; 61(11):645-652. PubMed ID: 35521817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence
    He Y; Chen X; Yu X
    Ann Clin Lab Sci; 2020 May; 50(3):412-416. PubMed ID: 32581037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.